Printer Friendly

BELMAC ELECTS NEW PRESIDENT AND CHIEF OPERATING OFFICERo

 TAMPA, Fla., Nov. 24 ~PRNewswire~ -- Michael M. Harshbarger was elected president and chief operating officer of Belmac Corporation (AMEX: BLM) at Monday's meeting of the board of directors. Most recently, he served as managing director of Healthcare Capital Group Inc., an investment banking firm based in Illinois and New York.
 Jean-Francois Rossignol, chairman and chief executive officer, said Harshbarger's addition to the Belmac management team will add tremendous strength during an important stage of the company's expansion.
 "Also, it will allow me to focus more of my attention on the implementation of the company's strategic plan, its fast-growing European operations, and positioning the company to enter the United States market," he added.
 Harshbarger brings to the company his experience in the marketing of pharmaceutical products for Hoffman-LaRoche and American Home Products as well as his extensive experience as an analyst in the healthcare industry for White Weld in New York and Hayes & Griffith in Chicago.
 Harshbarger believes Belmac represents one of the more interesting growth opportunities in today's corporate environment. "It's a specialty pharmaceutical firm with branded products and multinational interests. In reality, it is a microcosm of a large pharmaceutical company poised for dramatic growth."
 Harshbarger, whose firm has raised capital for Belmac in the past, said his priority is to assure investors that their investment is sound and the company's future growth strategy is keenly targeted.
 Harshbarger will initially focus on completing recently announced acquisitions in France and Italy, as well as evaluating new opportunities in the United States.
 Belmac Corporation is an international pharmaceutical company with a primary focus on the development and marketing of anti-infective drugs.
 -0- 11~24~92
 ~CONTACT: Michael D. Price of Belmac Corporation, 813-286-4401; or Harry Costello of Hill and Knowlton, 813-221-0030, for Belmac Corporation~
 (BLM)


CO: Belmac Corporation ST: Florida IN: MTC SU: PER

AW-JB -- FL003 -- 0948 11~24~92 10:02 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 24, 1992
Words:312
Previous Article:CORTECH ANNOUNCES INITIAL PUBLIC OFFERING
Next Article:ROBERT L. HEALY APPOINTED MANAGER OFFEDERAL GOVERNMENT RELATIONS FOR ARCO
Topics:


Related Articles
BELMAC RECEIVES $3.8 MILLION FROM WARRANT EXERCISE
AMEX OPENS OPTIONS TRADING ON BELMAC CORPORATION AND MGI PHARMA
BELMAC COMPLETES $11.6 MILLION PRIVATE OFFERING
BELMAC COMMENTS ON STOCK PRICE; SEES NO REASON FOR RECENT DECLINE
BELMAC COMMENTS ON STOCK PRICE
BELMAC COMPLETES PRIVATE PLACEMENT
BELMAC CORPORATION COMMENTS ON STOCK PRICE
BELMAC COMPLETES PRIVATE PLACEMENT
LIGHT ASSOCIATES, INC. PURCHASES BELMAC SHARES ON OPEN MARKET
BELMAC COMPLETES PRIVATE PLACEMENT; JAMES MURPHY NAMED CEO

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters